Literature DB >> 19513088

Tests to assess motor phenotype in mice: a user's guide.

Simon P Brooks1, Stephen B Dunnett.   

Abstract

The characterization of mouse models of human disease is essential for understanding the underlying pathophysiology and developing new therapeutics. Many diseases are often associated with more than one model, and so there is a need to determine which model most closely represents the disease state or is most suited to the therapeutic approach under investigation. In the case of neurological disease, motor tests provide a good read-out of neurological function. This overview of available motor tasks aims to aid researchers in making the correct choice of test when attempting to tease out a transgenic phenotype or when assessing the recovery of motor function following therapeutic intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19513088     DOI: 10.1038/nrn2652

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  234 in total

1.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive.

Authors:  Young-Gyun Park; Hye-Yeon Park; C Justin Lee; Soonwook Choi; Seonmi Jo; Hansol Choi; Yang-Hann Kim; Hee-Sup Shin; Rodolfo R Llinas; Daesoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

3.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

4.  Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo.

Authors:  Eugenia Trushina; Christie A Canaria; Do-Yup Lee; Cynthia T McMurray
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

5.  Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.

Authors:  Marta Garcia-Miralles; Michal Geva; Jing Ying Tan; Nur Amirah Binte Mohammad Yusof; Yoonjeong Cha; Rebecca Kusko; Liang Juin Tan; Xiaohong Xu; Iris Grossman; Aric Orbach; Michael R Hayden; Mahmoud A Pouladi
Journal:  JCI Insight       Date:  2017-12-07

6.  The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS.

Authors:  Ravinder Malik; Helen Meng; Piriya Wongkongkathep; Christian I Corrales; Niki Sepanj; Ryan S Atlasi; Frank-Gerrit Klärner; Thomas Schrader; Melissa J Spencer; Joseph A Loo; Martina Wiedau; Gal Bitan
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

Review 7.  Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome?

Authors:  Anna Rosell; Véronique Agin; Mahbubur Rahman; Anna Morancho; Carine Ali; Jari Koistinaho; Xiaoying Wang; Denis Vivien; Markus Schwaninger; Joan Montaner
Journal:  Transl Stroke Res       Date:  2013-01-09       Impact factor: 6.829

8.  Medial premotor cortex shows a reduction in inhibitory markers and mediates recovery in a mouse model of focal stroke.

Authors:  Steven R Zeiler; Ellen M Gibson; Robert E Hoesch; Ming Y Li; Paul F Worley; Richard J O'Brien; John W Krakauer
Journal:  Stroke       Date:  2013-01-15       Impact factor: 7.914

9.  In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.

Authors:  Laura Formentini; Marta P Pereira; Laura Sánchez-Cenizo; Fulvio Santacatterina; José J Lucas; Carmen Navarro; Alberto Martínez-Serrano; José M Cuezva
Journal:  EMBO J       Date:  2014-02-12       Impact factor: 11.598

10.  Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia.

Authors:  Fei Wang; Yu-Jian Yang; Nian Yang; Xian-Jun Chen; Nan-Xin Huang; Jun Zhang; Yi Wu; Zhi Liu; Xing Gao; Tao Li; Guang-Qiang Pan; Shu-Bao Liu; Hong-Li Li; Stephen P J Fancy; Lan Xiao; Jonah R Chan; Feng Mei
Journal:  Neuron       Date:  2018-08-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.